HEALTH PROBLEMS — NEUROLOGICAL

SORT date author clear filters


FILTER RECORDS BY


al-Razi (10th century CE; 4th century AH)
Kitab al-Hawi fi al-tibb [The comprehensive book of medicine].

View

Charleton R (1770)
An inquiry into the efficacy of warm bathing in palsies. Oxford: Clarendon.

View

Sims J (1774)
A discourse on the best methods of prosecuting medical enquiries. London: J Johnson, p78-9, 80, 86-88, 99-101.

View

Black W (1788)
A comparative view of the mortality of the human species at all ages. London: Dilly, pp 35-38.

View

Rollo J (1801)
A short account of the Royal Artillery Hospital at Woolwich. London: Mawman.

View

Falconer W (1807)
A practical dissertation on the effects of the medicinal effects of the Bath waters. London and Bath: Robinson & Crutwell. 3rd edition Bath: Meyler and London: Robinson, pp 29, 40-41, 50-52, 72-74, 99, 101, 106, 115-116, 117, 124.

View

Riding D, Corkhill NL (1932)
Prophylactic vaccination in epidemic meningococcal meningitis. Journal of Hygiene 32:258-267.

View

Macnamara J (1933)
Serum therapy in poliomyelitis. BMJ 1:526-8.

View

Walker MB (1934)
Treatment of myasthenia gravis with physostigmine. Lancet 1:1200-1201.

View

Gilliam AG, Onstott RH (1936)
Results of field studies with poliomyelitis vaccine. American Journal of Public Health 26:113-118.

View

Jolliffe N, Colbert CN (1936)
The etiology of polyneuritis in the alcohol addict. JAMA 107:642-7.

View

Goodhart R, Jolliffe N (1938)
Effects of vitamin B (B1) therapy on the polyneuritis of alcohol addicts. JAMA 110:414-419.

View

Banks HS (1939)
Chemotherapy of meningococcal meningitis. Lancet 2:921-927.

View

Gregory KK, West EJ, Stevens RE (1940)
Epidemic cerebrospinal meningitis (meningococcic): the treatment of 113 patients with antimeningococcus serum, meningococcus antitoxin and sulfanilamide. JAMA 115:1091-5.

View

Jordan JH, Blakelock, Johnston WR (1940)
Treatment of cerebrospinal fever with suphapyridine. BMJ 1:1005-1008.

View

Bahlke AM, Perkins JE (1945)
Gamma globulin in poliomyelitis. JAMA 129:1146-1150.

View

Kottke FJ, Teigen BS, Siegel S, Knapp ME (1948)
Evaluation of aids to muscle reeducation in the treatment of poliomyelitis. Archives of Physical Medicine and Rehabilitation 30:141-147.

View

Medical Research Council (1948)
Streptomycin treatment of tuberculous meningitis. Lancet 1:582-596.

View

Appelbaum E, Nelson J, Albin MB (1949)
The treatment of penumococcic meningitis with penicillin; a study of 125 consecutive cases, with 73% recovery. American Journal of Medicial Science 218:260-4.

View

Hammon W, Coriell LL, Stokes J (1952)
Evaluation of red cross gamma globulin as a prophylactic agent for poliomyelitis: 1. Plan of controlled field tests and results of 1951 pilot study in Utah. JAMA 150:739-749.

View

Bickel H, Gerrard J, Hickmans EM. (1953)
Influence of phenylalanine intake on phenylketonuria. Lancet 265:812-813.

View

Freed CR, Greene PE, Breeze RE, Tsai WY, DuMouchel W, Kao R, Dillon S, Winfield H, Culver S, Trojanowski JQ, Eidelberg D, Fahn S (2001)
Transplantation of embryonic dopamine neurons for severe Parkinson’s disease. New England Journal of Medicine 344:710–719.

View

Scott S, Kranz JE, Cole J, Lincecum JM, Thompson K, Kelly N, Bostrom A, Theodoss J, Al-Nakhala BM, Vieira FG, Ramasubbu J, Heywood JA (2008)
Design, power, and interpretation of studies in the standard murine model of ALS. Amyotrophic Lateral Sclerosis 9:4-15. DOI: 10.1080/17482960701856300.

View

Wartolowska KA, Collins GS, Hopewell S, Judge A, Dean BJF, Rombach I, Beard DJ, Carr AJ (2016)
Feasibility of surgical randomised controlled trials with a placebo arm: a systematic review. BMJ Open 6: p.e010194.

View

Misemer BS, Platts-Mills TF, Jones CW (2016)
Citation bias favoring positive clinical trials of thrombolytics for acute ischemic stroke: a cross-sectional analysis. Trials 17:473.

View

Show


Lee MR (2004).
The miracle of St. Alfege’s: discovering a treatment for myaesthenia gravis. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Ritskes-Hoitinga M, Pound P (2022).
The role of systematic reviews in identifying the limitations of preclinical animal research, 2000 – 2022. JLL Bulletin: Commentaries on the history of treatment evaluation.

View